相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer (vol 10, 28, 2019)
Bing Yao et al.
CELL DEATH & DISEASE (2022)
Regulation of epithelial-mesenchymal transition by protein lysine acetylation
Fanyun Kong et al.
CELL COMMUNICATION AND SIGNALING (2022)
Osteosarcoma and Metastasis Associated Bone Degradation-A Tale of Osteoclast and Malignant Cell Cooperativity
Kirstine Sandal Norregaard et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
Haydee M. Torres et al.
CANCERS (2021)
Spindle checkpoint: trapped by the corona, cyclin B1 goes MAD
Carlos Conde et al.
EMBO JOURNAL (2020)
CDK1-CCNB1 creates a spindle checkpoint-permissive state by enabling MPS1 kinetochore localization
Daniel Hayward et al.
JOURNAL OF CELL BIOLOGY (2019)
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines
Francesco Mararnpon et al.
CANCER LETTERS (2019)
MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2
Ruyi Zhang et al.
TUMOR BIOLOGY (2016)
A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
Takuya Sakamoto et al.
PLOS ONE (2016)
RUNX2 and Osteosarcoma
Na Li et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Histone deacetylase inhibitors in hematological malignancies and solid tumors
Pusoon Chun
ARCHIVES OF PHARMACAL RESEARCH (2015)
RUNX2 RNA interference inhibits the invasion of osteosarcoma
Heng Zeng et al.
ONCOLOGY LETTERS (2015)
Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review
N. C. Daw et al.
BRITISH JOURNAL OF CANCER (2015)
Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells
J. Bargiela-Iparraguirre et al.
CELL CYCLE (2014)
Growth Inhibition of Pancreatic Cancer Cells by Histone Deacetylase Inhibitor Belinostat Through Suppression of Multiple Pathways Including HIF, NFkB, and mTOR Signaling In Vitro and In Vivo
Wenwen Chien et al.
MOLECULAR CARCINOGENESIS (2014)
Translational biology of osteosarcoma
Maya Kansara et al.
NATURE REVIEWS CANCER (2014)
Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients
A. M. Hong et al.
ANNALS OF ONCOLOGY (2013)
The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines
Claudia M. J. Lucero et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
The HDAC interaction network
Ilana Livyatan et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer
Darryl T. Martin et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Upregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progression
Ling Yu et al.
ONCOLOGY REPORTS (2012)
Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
Dejuan Kong et al.
PLOS ONE (2012)
Mad2 Is a Critical Mediator of the Chromosome Instability Observed upon Rb and p53 Pathway Inhibition
Juan-Manuel Schvartzman et al.
CANCER CELL (2011)
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
J. PosthumaDeBoer et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma
Ling Yu et al.
APMIS (2010)
Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
Paul A. Marks
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases
Liliana Endo-Munoz et al.
CANCER RESEARCH (2010)
Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
Rocio Sotillo et al.
NATURE (2010)
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
Lisa Mirabello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression
Ana Patino-Garcia et al.
JOURNAL OF PEDIATRICS (2009)
Initial Testing (Stage 1) of Vorinostat (SAHA) by the Pediatric Preclinical Testing Program
Nino Keshelava et al.
PEDIATRIC BLOOD & CANCER (2009)
High-dose methotrexate in osteosarcoma: Let the questions surcease - Time for final acceptance
Norman Jaffe et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions
Agustin Valenzuela-Fernandez et al.
TRENDS IN CELL BIOLOGY (2008)
Metastasis: recent discoveries and novel treatment strategies
Suzanne A. Eccles et al.
LANCET (2007)
Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells
Arun Rajgopal et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Mad2 overexpression promotes aneuploidy and tumorigenesis in mice
Rocio Sotillo et al.
CANCER CELL (2007)
Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase
JR Whetstine et al.
MOLECULAR CELL (2005)
Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma
Y Cao et al.
CANCER RESEARCH (2005)
分享论文
